While the mechanisms of the promoting effect of LIF on the development and progression of solid tumors are not well-understood, our recent study showed that LIF is a novel negative regulator of p53 through the Stat3/ID1/MDM2 signaling in human colorectal cancers [17]. This evidence concerns the gene LIF and colorectal cancer.